Salgenx Unveils Revolutionary Saltwater Redox Flow Battery for Grid-Scale Energy Storage
3.12.2024 17:55:00 CET | Business Wire | Press release
Salgenx, a division of Infinity Turbine LLC, is proud to announce the launch of its groundbreaking saltwater redox flow battery, offering a sustainable and cost-effective alternative to traditional lithium-ion batteries for grid-scale energy storage.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203440827/en/
Salgenx Grid Scale 3000 kWh MegaWatt Pack Battery (Photo: Business Wire)
Key Advantages of Salgenx's Saltwater Redox Flow Battery:
- Enhanced Safety: Utilizing non-flammable, non-toxic materials, the saltwater battery significantly reduces risks associated with thermal runaway and fires, ensuring safer operation compared to lithium-ion counterparts.
- Environmental Sustainability: Constructed from abundant and eco-friendly materials including biochar from bamboo, the battery minimizes environmental impact and simplifies recycling processes, promoting a circular economy approach.
- Cost-Effectiveness: The use of widely available resources leads to lower production costs, making it a financially viable solution for large-scale energy storage needs.
- Scalability and Durability: Designed for easy scalability, the battery can be expanded to meet growing energy demands. Its robust architecture ensures a long cycle life with deep discharge capabilities, providing reliable performance over time.
Innovative Applications:
Beyond energy storage, the Salgenx saltwater redox flow battery offers multifunctional capabilities, including:
- Desalination: Simultaneously produces fresh water during the charging process, addressing water scarcity issues.
- Thermal Storage: The benefit of a grid-scale flow battery is the ability to simultaneously store hot or cold water, making it a Thermal Energy Storage (TES) device. Each battery can hold up to 48,000 liters of liquid thermal energy.
These unique features position the Salgenx battery as a versatile solution for various industrial applications, enhancing its value proposition in the energy storage market.
Grid-Scale Capacity:
The Salgenx system is engineered for large-scale energy storage, making it ideal for utility companies and renewable energy integration. Its modular design allows for seamless expansion, catering to diverse energy requirements and contributing to grid stability and resilience.
About Salgenx:
Salgenx, a division of Infinity Turbine LLC, specializes in innovative energy storage solutions. Committed to sustainability and technological advancement, Salgenx develops cutting-edge products that address the evolving needs of the energy sector.
Saltwater Battery Website: https://salgenx.com
Infinity Turbine Website: https://www.infinityturbine.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20241203440827/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Askey and Canoga Perkins Announce Strategic Collaboration at MWC Barcelona to Deliver Rapid-Deploy 5G Critical Communications Solutions27.3.2026 12:00:00 CET | Press release
Askeyand Canoga Perkinsannounced at Mobile World Congress Barcelona a Global Partnership to Deliver SyncMetra® Network Connectivity Solution, combining Canoga Perkins’ software-defined, IT-operated private 5G network transport along with Askey’s carrier-grade 5G radio access technology. At MWC Barcelona 2026, Askey Computer Corporation and Canoga Perkins announced a strategic partnership to deploy Canoga Perkins' SyncMetra® Platform across enterprise and service provider markets with Askey. This partnership pairs Askey’s carrier-grade radio access capabilities with Canoga Perkins’ industry-leading time-sensitive networking (TSN) and synchronization technology, enabling customers to simplify deployment of ultra-low-latency, highly reliable network services for 5G, edge compute, industrial automation, and mission-critical enterprise applications. The partnership enables joint go-to-market efforts, integrated product offerings, and expanded access to SyncMetra through Askey’s sales channe
SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results27.3.2026 11:40:00 CET | Press release
Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.14 for the three months ended December 31, 2025, representing 133% year-over-year increase. EBITDA1, which is calculated by adding depreciation and amo
NIQ Redefines Packaging Intelligence with Monthly, Harmonized Global Performance Visibility27.3.2026 11:00:00 CET | Press release
NIQ’s new solution brings unprecedented clarity into package types, materials, and true consumption across markets, closing critical industry gaps NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced the launch of its Packaging Strategic Planner Global (SPG) Solution, the first harmonized global platform to deliver monthly visibility into packaging performance across materials, formats, and pack configurations. As packaging innovation accelerates, many organizations continue to rely on fragmented or annual data to inform packaging decisions. The Packaging SPG Solution closes this gap by providing real-time data delivered monthly across regions, enabling brands and packaging partners to uncover trends, grow revenue, and strengthen relationships with CPG and retail partners. Key Highlights: New monthly global packaging tracking capability Coverage across 200+ categories Visibility into 30+ package types and 20 package materials 10+ markets at launch, expanding
European DataWarehouse Claims Its First “Fintech Provider of the Year” Award and a Sixth “Data Provider of the Year” Title at GlobalCapital’s 2026 European Securitisation Awards27.3.2026 08:47:00 CET | Press release
European DataWarehouse (EDW) is pleased to announce that it has been named both “Data Provider of the Year” and “Fintech Provider of the Year” at the 2026 GlobalCapital European Securitization Awards in London. The award ceremony recognises outstanding achievements in European structured finance, with winners selected by popular vote from across the industry. As defined by GlobalCapital, the programme celebrates “the very best in the market, as chosen by the market.” This latest recognition marks the sixth time that EDW has received the prestigious Data Provider of the Year award, having previously been honoured in 2019, 2022, 2023, 2024 and 2025, reaffirming its long-standing commitment to transparency, data quality and innovation in European securitisation. Prof. José Manuel González-Páramo, Chairman of EDW, later commented: “ Winning this award for the sixth time highlights the continued trust the European securitisation market places in EDW. Transparency, data quality and reliabili
Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors27.3.2026 01:00:00 CET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner NEOK Bio, Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for NEOK002, an EGFR/MUC1-targeting ADC program for solid tumors. NEOK Bio plans to initiate a Phase 1 clinical study in the second quarter of 2026 and expects to report initial data in 2027. This IND clearance marks an important milestone for NEOK002, an EGFR/MUC1-targeting ADC candidate developed by NEOK Bio and built on a bispecific antibody originally developed by Biocytogen and licensed in 2024. According to NEOK Bio, NEOK002 is being advanced for solid tumors and may offer differentiated efficacy and safety compared with monospecific ADC approaches directed at either target alone. Dr. Yuelei Sh
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom